Cancidas
Active Ingredient(s): CaspofunginFDA Approved: * January 26, 2001
Pharm Company: * MERCK RES
Category: Antifungal
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Cancidas Overview
Caspofungin (INN)[1][3] (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard.[4] It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Caspofungin
Recent Cancidas Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Caspofungin
- Injection: 50mg, 50mg/vial, 70mg, 70mg/vial
- Powder: 50mg/vial, 70mg/vial
NDC Database Records for Cancidas: (2 results)
Sorted by National Drug Code- 0006-3822 Cancidas 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.
- 0006-3823 Cancidas 7 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.